Guiding industry professionals to better recognize the requirements within new legislation and adhering it to their daily lives with functional tools they will learn here with real-world case studies and examples will create and maintain industry leaders.
Horsham, PA (PRWEB) September 25, 2012
DIA, the premier organization dedicated to knowledge exchange that fosters innovation to raise the level of health and well-being worldwide is proud to host Principles and Practical Approaches to Global Risk Management, October 9-10 at the Silver Spring Civic Building in Silver Spring, MD. This highly interactive conference is specifically for those within the regulatory and industry areas with concentration on benefit-risk management throughout the biopharmaceutical product life cycle and effective approaches to implantation as well as discussing new trends and tools.
“This meeting brings together the best thought leaders in risk management such as Gerald Dal Pan, MD, Director, Office of Surveillance and Epidemiology, CDER, FDA; Hazuki Takaura, MS, Safety Division, Ministry of Health, Labour and Welfare, Japan; and Mark A. Collins, PhD, MBA, Director, Pharmacovigilance and Risk Management, Endo Pharmaceuticals Inc., among other invited informative presenters,” maintains Robin Gellar, Director of Pharmacovigilance Intelligence and Safety Writing, Global Pharmacovigilance, of Baxter Healthcare Corporation, one of the meeting’s Session Chairpersons. “Guiding industry professionals to better recognize the requirements within new legislation and adhering it to their daily lives with functional tools they will learn here with real-world case studies and examples will create and maintain industry leaders.”
Travel Once, Learn Twice! Register for both events today.
Principles and Practical Approaches to Global Risk Management, October 9-10, Silver Spring, MD and Global Labeling 2012: Impact on Risk Management & Other Global and Regional Initiatives, October 11-12, Silver Spring, MD.
DIA is a neutral, global, professional, member-driven association of nearly 18,000 professionals involved in the discovery, development, and life cycle management of pharmaceuticals, biotechnology, medical devices and related medical products. Through our international educational offerings and myriad networking opportunities, DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies and services to improve health and well being worldwide. Headquarters are in Horsham, PA, USA, with offices in Basel, Switzerland; Tokyo, Japan; Mumbai, India; and Beijing, China. http://www.diahome.org Follow DIA on Facebook, Twitter, LinkedIn, and YouTube. Stay updated on hot topic news at #druginfoassn on Twitter.